Viewing Study NCT01935492

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:29 PM
Ignite Modification Date: 2026-01-31 @ 8:30 PM
Study NCT ID: NCT01935492
Status: COMPLETED
Last Update Posted: 2020-01-18
First Post: 2010-11-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: 8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer
Sponsor: Borstkanker Onderzoek Groep
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Human Epidermal Growth Factor 2 Negative Carcinoma of Breast View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic breast cancer View
None HER2/neu negative View
None paclitaxel View
None bevacizumab View
None liposomal doxorubicine View
None capecitabine View